Company Update

Transgene Biotek has confirmed, via its share transfer agent, that no physical shares were converted to electronic form (dematerialized) or vice-versa (rematerialized) during the quarter from April 1 to June 30. This update is part of routine compliance, ensuring transparent and accurate records of investor shareholdings.

It signifies a stable period concerning the physical-to-electronic conversion of shares.